C. Trade Negotiating Bi-Agra™ Manufacturing and Distribution Expansion in International Markets

CARLSBAD, Calif. – November 19, 2012 - Green
Mountain Development Corp (Pinksheet: GMND), announced today that GMND director and C. Trade CEO,
Nick Kontonicolas, is negotiating domestic and international licensing rights
for the GMND Bi-Agra™ agricultural products with a major biotech firm which has
the technological expertise to manufacture and produce microbial products under
controlled conditions. The company hopes
to conclude the negotiations this month and expand production of Bi-Agra™ into
international markets in 2013. The
Bi-Agra™ products have demonstrated increased yields for many food and fuel
crops.

Green
Mountain and strategic partner C. Trade want to expand Bi-Agra™ manufacturing
capacity by licensing the technology to a major biotech firm capable of direct
production and distribution rather than using contract manufacturing and self
distribution. The company has received numerous international inquiries to use
and distribute the Bi-Agra™ agricultural products that increase plant health
and product yields. C. Trade is reviewing different business structures in its
quest to integrate into the biotech arena.

About Green Mountain Development Corp

Green Mountain
Development Corp provides project development services for capital providers
and technology operators and distributes licensed products related to the
energy, agricultural and environmental sectors.

About C.
Trade Group

C. Trade Group, Nick Kontonicolas, President
and Affiliates have interests in energy exploration and logistics, real estate,
transportation and technology with affiliated offices in New York, Shanghai,
California, Calgary, Athens, Jinzhou, China and Abu Dhabi. Mr. Kontonicolas can be contacted at +1 917
297-5571 or at ctradeusa@juno.com

Investors and
media contact Robert Brehm at 619/488-3744 (bob@greenbizness.com) or visit the
corporate website www.GreenBizness.com
for news and updates.

The information contained in this press release
includes forward-looking statements. Forward-looking statements usually contain
the words "estimate," "anticipate," "believe,"
"expect" or similar expressions that involve risks and uncertainties.
These risks and uncertainties include the company's
status as a development stage company with uncertain profitability, need for
significant capital, uncertainty concerning market acceptance of its products,
competition, limited service and manufacturing facilities, dependence on
technological developments and protection of its intellectual property. The
company's actual results could
differ materially from those discussed herein.